Troy Kanji

Troy Kanji is an analyst at Boost VC, a pre-seed venture capital firm in San Mateo focused on deep tech investments. With a background in molecular biology from Brown University—where he researched ALS using Drosophila genetics—he bridges the worlds of science and finance. Before Boost VC, he cut his teeth at Trinity Life Sciences, F-Prime Capital (genomics), and Castle Island Ventures (crypto), building a unique cross-disciplinary lens. He's also co-founder and board member of Revalia Bio, a Yale spinout revolutionizing drug development with human data trials using donated organs.